Abstract
Background There are no known objective biomarkers for predicting Return to Work (RTW) in ischemic stroke survivors. This study aims to explore the predictive utility and define a cut-off value of lesion volume on RTW after endovascular treatment (EVT).
Methods We included patients <65 years undergoing EVT at Oslo University Hospital (OUS) between January 2017 and May 2019. Employment status was obtained at both baseline and a four-year follow-up. Stroke lesion volumes were segmented using magnetic resonance imaging (MRI) scans 24 hours post EVT. Logistic regression models were conducted to assess the impact of lesion volume on RTW-status at follow-up, adjusted for patients’ characteristics, stroke related factors and treatment. We calculated the Receiver Operating Characteristic curve to determine the optimal lesion volume cut-off. Machine learning (ML) regression models were employed to assess the predictive abilities of baseline clinical and imaging variables for RTW.
Results Of the 109 individuals treated, 81 (74%) were employed at baseline. Among these, 60 completed four-year follow-up with MRI available for stroke lesion segmentation and were included in the analyses. Mean age at stroke onset was 51.8 years (range 23.5–64.9), 50% were female. Median lesion volume was 18 ml (IQR 45-7). After four years, 34 (57%) had successfully RTW. The odds for not RTW increased by 5% for every 1 ml increase in lesion volume (adjusted odds ratio [aOR], 95% CI, 1.02–1.11], P=0.02). A lesion volume cut-off value of 29 cm3 yielded a sensitivity of 0.91 and specificity of 0.65 for predicting RTW. Notably, the most influential feature in the ML model for predicting RTW was lesion volume.
Conclusion Lesion volume was the most robust predictor of RTW four years after EVT. Our findings suggest that a cut-off of 29 cm3 is suitable to distinguish between those with high and low chance of RTW.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT06220981
Funding Statement
This paper was funded by a grant from South-Eastern Norway Regional Health Authority. The OSCAR registry was funded by Oslo University Hospital. Additional funding for the project was obtained from Bærum Vestre Viken Hospital Trust, and The National Association for Stroke Victims, Norway
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study received approval from the regional ethics committee (Regional Committee for Medical Ethics Southeast Norway, (REC ID: 152864)).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Non-standard abbreviations and acronyms
- AI
- Artificial Intelligence
- DWI
- Diffusion Weighted Imaging
- EVT
- Endovascular treatment
- IVT
- Intravenous Thrombolysis
- MCA
- Middle Cerebral Artery
- ML
- Machine Learning
- MRI
- Magnetic Resonance Imaging
- mRS
- Modified Rankin Scale
- NIHSS
- National Institute of Health Stroke Scale
- NRTW
- Not Return to Work
- OR
- Odds Ratio
- OSCAR
- The Oslo Acute Reperfusion Stroke Study
- RTW
- Return to Work
- mTICI
- modified Thrombolysis in Cerebral Ischemia